FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/05/008719 [Registered on: 31/05/2017] Trial Registered Retrospectively
Last Modified On: 31/05/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   EFFECT OF GUDUCHYADICHURNA AND ELADICHURNA IN AMLAPITTA(HYPERACIDITY) 
Scientific Title of Study   A CLINICAL STUDY OF GUDUCHYADICHURNA AND ELADI CHURNA IN THE MANAGEMENT OF AMLAPITTA 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  MOHIT PRAVINBHAI PAGHDAR 
Designation  MD 
Affiliation  GOVT AKHANDANAND AYURVED COLLEGE 
Address  GOVT AKHANDANAND AYURVED COLLEGE BHADRA ROOM NO 9 KAYACHIKITSAA DEPARTMENT AHMADABAD

Ahmadabad
GUJARAT
380001
India 
Phone  8866608559  
Fax    
Email  dr.mppaghdar273@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR BHARAT MUNGARA 
Designation  ASSOCIATE PROFESSOR 
Affiliation  GOVT AKHANDANAND AYURVED COLLEGE BHADRA AHMEDABAD 
Address  GOVT AKHANDANAND AYURVED COLLEGE BHADRA AHMEDABAD

Ahmadabad
GUJARAT
380001
India 
Phone  9426336822  
Fax    
Email  patanjaliayucare@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  MOHIT PRAVINBHAI PAGHDAR 
Designation  MD 
Affiliation  GOVT AKHANDANAND AYURVED COLLEGE 
Address  GOVT AKHANDANAND AYURVED COLLEGE BHADRA ROOM NO 9 KAYACHIKITSAA DEPARTMENT AHMADABAD

Ahmadabad
GUJARAT
360410
India 
Phone  8866608559  
Fax    
Email  dr.mppaghdar273@gmail.com  
 
Source of Monetary or Material Support  
GOVERNMENT AKHANDANAND AYURVED COLLEGE BHADRA AHMEDABAD 
 
Primary Sponsor  
Name  GOVT AKHANDANAND AYURVED COLLEGE  
Address  GOVT AKHANDANAND AYURVED COLLEGE BHADRA AHMEDABAD 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR MOHIT PAGHDAR  AKHANDANAND AYURVED COLLEGE  ROOM NO 9 KAYACHIKITSA DEPARTMENT AKHANDANAND AAYURVED COLLEGE BHADRA AHMEDABAD
Ahmadabad
GUJARAT 
8866608559

dr.mppaghdar273@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  PATIENT SUFFERING FROM AMLAPITTA.,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  A CLINICAL STUDY OF GUDUCHYADICHURNA IN THE MANAGEMENT OF AMLAPITTA  15 patients will be taken in group A and will be treated with Guduchyadi churna in following dose and duration Dose: 10gm/day two divided dose with water Duration: 4 weeks  
Comparator Agent  A CLINICAL STUDY OF ELADI CHURNA IN THE MANAGEMENT OF AMLAPITTA  15 patients will be taken in group B and will be treated with ELADI CHURNA in following dose and duration Dose: 10gm/day two divided dose with water Duration: 4 weeks 
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with classical signs & symptoms of Amlapitta.Avipaka (Indigestion), Klama(Lassitude), Utklesha (Nausea), Tiktodgara(Bitter eruction), Amlodgara(sour eruction),Gaurav(heaviness of body),Hrit Daha(Heart buru), Kantha Daha (Burning in throat), Aruchi (Anorexia). 
 
ExclusionCriteria 
Details  Patients suffering from Hematemesis, Acute diarrhoea, Intestinal T.B, Gastric and Peptic ulcer, uncontrolled D.M. and HTN, Arsha, Carcinoma, cardiac disorders etc. serious condition of the patient. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Result will be assessed on the basis of relief in the Signs and symptoms of Amlapitta   4 WEEKS 
 
Secondary Outcome  
Outcome  TimePoints 
Result will be assessed on the basis of relief in the Signs and symptoms of Amlapitta   4 weeks  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   23/05/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomised, participants blinded, parallel group, active controlled trial to evaluate the efficacy of Guduchyadi Churna in a  Dose of  10gm/day two divided dose with water Duration: 4 weeks in 15 patients with GROUP A and also  to evaluate the efficacy of  Eladi Churna in a Dose of  10gm/day two divided dose with water Duration: 4 weeks in 15 patients of GROUP B in Amlapitta.

 
Close